Has Mia Wong received payments from drug or device companies?

Yes. Drug and device makers reported $18,948 in general payments to Mia Wong across 749 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mia Wong did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mia Wong come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mia Wong

Nurse Practitioner · Los Angeles, CANPI 1336874635

Payments from drug & device makers

$18,948in general payments, 2019–2025

Across 749 payments — averaging $25.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Exelixis Inc.$1K
Johnson & Johnson$1K
AstraZeneca$954
Incyte Corporation$929
Takeda Pharmaceuticals U.S.A., Inc.$851
Daiichi Sankyo Inc.$831
plus $13K from 54 others

What the payments were for

Food & beverage$18,05295%
Education$8965%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Exelixis Inc.	13	$1,249
Johnson & Johnson	41	$1,107
AstraZeneca(2 entities)	33	$954
Incyte Corporation	32	$929
Takeda Pharmaceuticals U.S.A., Inc.	30	$851
Daiichi Sankyo Inc.	40	$831
Novartis	58	$805
Merck	27	$776
Pfizer	41	$725
Bristol Myers Squibb	36	$658
Astellas Pharma US Inc	30	$635
Genentech USA, Inc.	35	$574
Tersera Therapeutics LLC	21	$535
E.r. Squibb & Sons, L.L.C.	24	$531
Array Biopharma Inc	25	$496
Gilead	15	$440
Sanofi	13	$437
Lilly USA, LLC	11	$379
GSK	18	$330
AbbVie	15	$325
Myriad Genetic Laboratories, Inc.	3	$313
Seagen Inc.	5	$273
Puma Biotechnology, Inc.	11	$257
Bayer	11	$256
Sobi, Inc	6	$245
Ipsen Biopharmaceuticals, Inc	9	$232
Boehringer Ingelheim	8	$222
Deciphera Pharmaceuticals Inc.	9	$209
Amgen	11	$203
Pharmaessentia USA Corporation	8	$185
AVEO Pharmaceuticals, Inc.	6	$183
Blueprint Medicines Corporation	6	$171
EMD Serono, Inc.	4	$170
Eisai Inc.	7	$170
Taiho Oncology, Inc.	6	$161
Jazz Pharmaceuticals Inc.	5	$151
Pharmacosmos Therapeutics Inc.	2	$147
Coherus Oncology, Inc.	6	$132
ADC Therapeutics America, Inc.	5	$121
Agios Pharmaceuticals, Inc.	4	$111
Karyopharm Therapeutics Inc.	3	$104
Stemline Therapeutics Inc.	4	$98
Morphosys, US Inc.	4	$92
Progenics Pharmaceuticals, Inc.	3	$79
Acrotech Biopharma Inc.	3	$76
Sumitomo Pharma America, Inc.	3	$71
Springworks Therapeutics, Inc.	2	$67
Genmab U.S., Inc.	2	$67
Dendreon Pharmaceuticals LLC	2	$63
Mirati Therapeutics, Inc.	3	$57
Rigel Pharmaceuticals, Inc.	3	$55
Recordati_rare_diseases_inc.	2	$50
Octapharma USA, Inc.	2	$50
Adaptive Biotechnologies Corporation	2	$48
Sun Pharmaceutical Industries Inc.	2	$48
Immunogen, Inc.	2	$48
Novocure Inc.	2	$46
Regeneron Healthcare Solutions, Inc.	1	$34
Beigene USA, Inc.	1	$34
Emmaus Medical, Inc.	2	$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,948 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Morphine Sulfate ErMorphine Sulfate	13	$789
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	38	$467

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Los Angeles

Kristin HorwoodLos Angeles$99K
Yunying ChenLos Angeles$80K
Lauren BristowLos Angeles$46K
Rhonda HewittStanford$917K
Linda TrinhIrvine$899K
Denise SinagaNorthridge$728K
Debbie TaySanta Monica$642K
Joe GorelickCampbell$638K
Lynsey LakinArcadia$540K
Kelly ChoiRancho Cucamonga$483K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →